$NAUT next to run, $AMZN invested in them$NAUT undervalued and ALOT of insider and institutional buying past 2 weeks at $7+ discounted right now and $AMZN invested
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.56 USD
−63.67 M USD
0.00 USD
75.09 M
About Nautilus Biotechnology, Inc.
Sector
Industry
CEO
Sujal M. Patel
Website
Headquarters
Seattle
Founded
2016
FIGI
BBG00W7G4M12
Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NAUT is 2.49 USD — it has decreased by −6.39% in the past 24 hours. Watch Nautilus Biotechnology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Nautilus Biotechnology, Inc. stocks are traded under the ticker NAUT.
NAUT stock has fallen by −6.04% compared to the previous week, the month change is a −7.43% fall, over the last year Nautilus Biotechnology, Inc. has showed a −8.46% decrease.
We've gathered analysts' opinions on Nautilus Biotechnology, Inc. future price: according to them, NAUT price has a max estimate of 5.00 USD and a min estimate of 2.25 USD. Watch NAUT chart and read a more detailed Nautilus Biotechnology, Inc. stock forecast: see what analysts think of Nautilus Biotechnology, Inc. and suggest that you do with its stocks.
NAUT reached its all-time high on Aug 5, 2021 with the price of 12.38 USD, and its all-time low was 1.50 USD and was reached on Dec 19, 2022. View more price dynamics on NAUT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NAUT stock is 9.84% volatile and has beta coefficient of 1.22. Track Nautilus Biotechnology, Inc. stock price on the chart and check out the list of the most volatile stocks — is Nautilus Biotechnology, Inc. there?
Today Nautilus Biotechnology, Inc. has the market capitalization of 312.65 M, it has decreased by −2.45% over the last week.
Yes, you can track Nautilus Biotechnology, Inc. financials in yearly and quarterly reports right on TradingView.
Nautilus Biotechnology, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
NAUT earnings for the last quarter are −0.13 USD per share, whereas the estimation was −0.17 USD resulting in a 21.21% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Nautilus Biotechnology, Inc. earnings.
Nautilus Biotechnology, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
NAUT net income for the last quarter is −16.45 M USD, while the quarter before that showed −18.01 M USD of net income which accounts for 8.68% change. Track more Nautilus Biotechnology, Inc. financial stats to get the full picture.
No, NAUT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 167.00 employees. See our rating of the largest employees — is Nautilus Biotechnology, Inc. on this list?
Like other stocks, NAUT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nautilus Biotechnology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nautilus Biotechnology, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nautilus Biotechnology, Inc. stock shows the sell signal. See more of Nautilus Biotechnology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.